10x Genomics Inc logo

10x Genomics Inc

$ 47.58 -0.66 (-1.37%) 11:08 PM EST
P/E:
At Loss
P/B:
6.91
Market Cap:
$ 5.42B
Enterprise V:
$ 5.09B
Volume:
855.48K
Avg Vol (2M):
1.61M
Also Trade In:
Volume:
855.48K
Market Cap $:
5.42B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.61M
Enterprise Value $:
5.09B
PB Ratio:
6.91
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

10x Genomics Inc
NAICS : 621999 SIC : 8099
6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
Description
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Name Current Vs Industry Vs History
Cash-To-Debt 5.05
Equity-to-Asset 0.78
Debt-to-Equity 0.13
Debt-to-EBITDA -0.93
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 14.46
Distress
Grey
Safe
Beneish M-Score -2.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 78.85
9-Day RSI 71.3
14-Day RSI 62.43
6-1 Month Momentum % -62.33
12-1 Month Momentum % -77.6

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.65
Quick Ratio 5.05
Cash Ratio 4.24
Days Inventory 200.73
Days Sales Outstanding 55.14
Days Payable 66.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.7

Financials (Next Earnings Date:2022-11-03 Est.)

TXG's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:TXG

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 497.932
EPS (TTM) ($) -1.26
Beta 0
Volatility % 50.28
14-Day RSI 62.43
14-Day ATR ($) 3.258167
20-Day SMA ($) 41.0325
12-1 Month Momentum % -77.6
52-Week Range ($) 33.3 - 191.1525
Shares Outstanding (Mil) 113.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

10x Genomics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More